Related Experiment Video
Updated: Aug 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction
Lars Køber1, Karl Swedberg, John J V McMurray
1Department of Cardiology, Non-Invasive Lab, Rigshospitalet, 9 Blegdamsvej, Copenhagen, Denmark. LK@HEART.DK
Insights
Atrial fibrillation (AF) significantly increases mortality and major cardiovascular events in patients with acute myocardial infarction (MI) complicated by heart failure (HF) or left ventricular systolic dysfunction (LVSD). This risk applies to both current and prior AF diagnoses.
Area of Science:
- Cardiology
- Clinical Research
- Epidemiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- Acute myocardial infarction (MI) with heart failure (HF) or left ventricular systolic dysfunction (LVSD) represents a high-risk patient population.
- The impact of AF on outcomes in this specific complex patient group requires further characterization.
Purpose of the Study:
- To investigate the relationship between atrial fibrillation (AF) and outcomes in patients with acute myocardial infarction (MI).
- To assess the risk of death and major cardiovascular (CV) events in patients with MI complicated by heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) in the presence of AF.
- To differentiate outcomes based on current versus prior AF diagnoses.
Main Methods:
- Analysis of data from the VALIANT trial, which enrolled 14,703 patients with acute MI, HF, and/or LVSD.
- Assessment of AF status at presentation and randomization (median 4.9 days post-MI).
- Evaluation of primary outcomes including all-cause mortality and major CV events at 3 years post-MI.
Main Results:
- The study included 1812 patients with current AF, 339 with prior AF, and 12,509 without AF.
- Patients with AF were older and had more comorbidities.
- Three-year mortality was significantly higher in patients with current AF (38%) and prior AF (37%) compared to those without AF (20%).
- Multivariable analysis showed increased hazard ratios for death (1.32 for current AF, 1.25 for prior AF) and major CV events (1.21 for current AF) in patients with AF.
Conclusions:
- Atrial fibrillation (AF) is a significant independent predictor of adverse outcomes in patients with acute myocardial infarction (MI) complicated by heart failure (HF) or left ventricular systolic dysfunction (LVSD).
- Both current and prior AF are associated with increased long-term mortality and major cardiovascular events.
- These findings underscore the importance of managing AF in high-risk MI patients.
Aims:
To characterize the relationship between known and newly diagnosed atrial fibrillation (AF) and the risk of death and major cardiovascular (CV) events in patients with acute myocardial infarction (MI) complicated by heart failure (HF) and/or left ventricular systolic dysfunction (LVSD).
Methods:
The VALIANT trial enrolled 14,703 individuals with acute MI complicated by HF and/or LVSD. AF was assessed at presentation and at randomization (median 4.9 days after symptom onset). Primary outcomes were risk of death and major CV events 3 years following acute MI.
Results:
A total of 1812 with current AF (AF between presentation and randomization), 339 patients with prior AF (history of AF without current AF), and 12,509 without AF were enrolled. Patients with AF were older; had more prior HF, angina, and MI, and received beta-blockers and thrombolytics less often than those without AF. Three-year mortality estimates were 20% in those without AF, 37% with current AF, and 38% with prior AF. Compared with patients without AF, the multivariable adjusted HR of death was 1.25 (1.03-1.52; p=0.03) for prior AF and 1.32 (1.20-1.45; p<0.0001) for current AF. HR for major CV events was 1.15 (0.98-1.35; p=0.08) and 1.21 (1.12-1.31; p<0.0001).
Conclusion:
AF is associated with greater long-term mortality and adverse CV events with acute MI complicated by HF or LVSD.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Heart Failure IV: Classification and Diagnostic Evaluation
Aortic Regurgitation III: Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

